|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aquinox Pharmaceuticals Inc.
| | | Phone: | (604) 629-9223 | Fax: | (604) 880-0286 | Year Established: | 2004 | Ticker: | AQXP | Exchange: | NASDAQ | Main Contact: | Lloyd Mackenzie, COO & VP, R&D Operations | | Other Contacts: | David J. Main, President & CEO Kamran Alam, VP, Finance & CFO
| | Company Description | Aquinox Pharmaceuticals is a privately-held pharmaceutical company developing targeted small molecule therapeutics for the treatment of cancer and inflammatory disease. The Company has a strong intellectual property portfolio and library of pre-clinical drug candidates that target a unique biochemical enzyme called "SHIP" (SH2-containing inositol phosphatase) which regulates the PI3 kinase (PI3K) pathway. The Company is based on the research of its four key scientific founders from the University of British Columbia and the BC Cancer Agency in Vancouver. | |
|
|
|
|
|